ALT
NASDAQ · Biotechnology
Altimmune Inc
$1.97
-0.15 (-7.08%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+435.5% upside
Low Target
$6.68
Average Target
$10.55
High Target
$11.58
Current Price
$1.97
Current
$1.97
$1.97
Target
$10.55
$10.55
$6.68
$10.55 avg
$11.58
Scenario Analysis
Bear Case
$6.68
239.1%
Low target
Base Case
$10.55
+435.5%
Avg target
Bull Case
$11.58
+487.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$6.44
-69.4% from high
52-Week Low
$2.00
+-1.3% from low
Target vs 52W High
$10.55
+63.8% vs high
Next Earnings Report
Nov 10, 2026 · Before Market Open
2d
until earnings
EPS Est: $-0.14
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |